FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

ACBMACRO BIOMEDICAL CO., LTD.

Inspect →

ACCLAcco Group Holdings Ltd

Inspect →

ACCOACCO BRANDS Corp

Inspect →

ACCSACCESS Newswire Inc.

Inspect →

ACCVAccelevation Holdings Corp.

Inspect →

ACDCProFrac Holding Corp.

Inspect →

ACELAccel Entertainment, Inc.

Inspect →

ACETAdicet Bio, Inc.

Inspect →

ACFNACORN ENERGY, INC.

Inspect →

ACGCACP Holdings Acquisition Corp.

Inspect →

ACGLARCH CAPITAL GROUP LTD.

Inspect →

ACGPAssociated Capital Group, Inc.

Inspect →

03 / FINANCIAL CHANGES

Harmony Biosciences Holdings, Inc. HRMY

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-04 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2025-09-30.

Revenue268.92

USD million

Change year over year: +29.46 · +12.3%

Net income48.20

USD million

Change year over year: -2.67

Operating cash flow76.69

USD million

Change year over year: -32.04

Total liabilities406.01

USD million

Change year over year: +32.92

Total assets1,478.25

USD million

Change year over year: +270.03

Liabilities / assets: 27.5% · Change: -3.4 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-02-24 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2024-12-31.

Revenue868.45

USD million

Change year over year: +153.72 · +21.5%

Net income158.69

USD million

Change year over year: +13.19

Operating cash flow348.20

USD million

Change year over year: +128.38

Total liabilities401.41

USD million

Change year over year: +61.37

Total assets1,271.63

USD million

Change year over year: +272.43

Liabilities / assets: 31.6% · Change: -2.5 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
NUVB ↗	2025-12-31	62.90	-325.3%	-275.7%
DSGN ↗	2025-12-31	0.00	—	—
LYEL ↗	2025-12-31	0.04	-762,355.6%	-416,733.3%
RPRX ↗	2025-12-31	2,378.19	32.4%	104.7%
ARQT ↗	2025-12-31	372.07	-4.3%	-1.5%
MIRM ↗	2025-12-31	521.31	-4.5%	10.7%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

TPL ↗

Texas Pacific Land Corp

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

NUVB ↗

Nuvation Bio Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

DSGN ↗

Design Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

OZ ↗

Belpointe PREP, LLC

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

LYEL ↗

Lyell Immunopharma, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ADEA ↗

Adeia Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RPRX ↗

Royalty Pharma plc

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

HRMY ↗

Harmony Biosciences Holdings, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RYM ↗

RYTHM, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

GTBIF ↗

Green Thumb Industries Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

SLQT ↗

SelectQuote, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

GTM ↗

ZoomInfo Technologies Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →